These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


127 related items for PubMed ID: 9808396

  • 1. Safety of hormonal replacement therapy in postmenopausal patients with systemic lupus erythematosus.
    Mok CC, Lau CS, Ho CT, Lee KW, Mok MY, Wong RW.
    Scand J Rheumatol; 1998; 27(5):342-6. PubMed ID: 9808396
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Hormone replacement therapy in systemic lupus erythematosus.
    Kreidstein S, Urowitz MB, Gladman DD, Gough J.
    J Rheumatol; 1997 Nov; 24(11):2149-52. PubMed ID: 9375875
    [Abstract] [Full Text] [Related]

  • 4. Hormone replacement therapy in women with systemic lupus erythematosus and risk of cardiovascular disease.
    Hochman J, Urowitz MB, Ibañez D, Gladman DD.
    Lupus; 2009 Apr; 18(4):313-7. PubMed ID: 19276299
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tibolone in postmenopausal women with systemic lupus erythematosus: a pilot study.
    Vieira CS, Pereira FV, de Sá MF, Paulo LJ, Martins WP, Ferriani RA.
    Maturitas; 2009 Mar 20; 62(3):311-6. PubMed ID: 19193505
    [Abstract] [Full Text] [Related]

  • 11. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA L II): relationship between vascular events and the use of hormone replacement therapy in postmenopausal women.
    Fernández M, Calvo-Alén J, Bertoli AM, Bastian HM, Fessler BJ, McGwin G, Reveille JD, Vilá LM, Alarcón GS.
    J Clin Rheumatol; 2007 Oct 20; 13(5):261-5. PubMed ID: 17921793
    [Abstract] [Full Text] [Related]

  • 12. Menopause hormonal therapy in women with systemic lupus erythematosus.
    Sánchez-Guerrero J, González-Pérez M, Durand-Carbajal M, Lara-Reyes P, Jiménez-Santana L, Romero-Díaz J, Cravioto MD.
    Arthritis Rheum; 2007 Sep 20; 56(9):3070-9. PubMed ID: 17763408
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Safety of hormonal replacement therapy and oral contraceptives in systemic lupus erythematosus: a systematic review and meta-analysis.
    Rojas-Villarraga A, Torres-Gonzalez JV, Ruiz-Sternberg ÁM.
    PLoS One; 2014 Sep 20; 9(8):e104303. PubMed ID: 25137236
    [Abstract] [Full Text] [Related]

  • 16. Extrarenal disease activity in systemic lupus erythematosus is not suppressed by chronic renal insufficiency or renal replacement therapy.
    Bruce IN, Hallett DC, Gladman DD, Urowitz MB.
    J Rheumatol; 1999 Jul 20; 26(7):1490-4. PubMed ID: 10405935
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Estrogen use in systemic lupus erythematosus].
    Ketari S, Cherif O, Boussema F, Kochbati S, Ben Dhaou B, Rokbani L.
    Gynecol Obstet Fertil; 2005 Oct 20; 33(10):783-90. PubMed ID: 16139552
    [Abstract] [Full Text] [Related]

  • 19. Disease activity during the premenopausal and postmenopausal periods in women with systemic lupus erythematosus.
    Sánchez-Guerrero J, Villegas A, Mendoza-Fuentes A, Romero-Díaz J, Moreno-Coutiño G, Cravioto MC.
    Am J Med; 2001 Oct 15; 111(6):464-8. PubMed ID: 11690572
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.